Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 143 articles:
HTML format
Text format



Single Articles


    December 2017
  1. YEUNG Y, Barra LJ
    Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
    J Rheumatol. 2017;44:1942-1943.
    PubMed     Text format    


  2. NAVRATIL M, Ivkovic Jurekovic I
    Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    J Rheumatol. 2017;44:1940.
    PubMed     Text format    


  3. BLOCKMANS D
    Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
    J Rheumatol. 2017;44:1763-1764.
    PubMed     Text format    


    November 2017
  4. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
    PubMed     Text format     Abstract available


  5. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Text format     Abstract available


  6. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
    Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
    J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
    PubMed     Text format     Abstract available


  7. TSELIOS K, Gladman DD, Su J, Ace O, et al
    Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
    J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
    PubMed     Text format     Abstract available


    October 2017
  8. VITIELLO G, Cammelli D
    Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
    J Rheumatol. 2017;44:1566.
    PubMed     Text format    


  9. CHEN Y, Liu J
    What is the Definition of the Anticytoplasmic Autoantibody?
    J Rheumatol. 2017;44:1564.
    PubMed     Text format    


    September 2017
  10. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
    Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
    PubMed     Text format     Abstract available


  11. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
    Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
    PubMed     Text format     Abstract available


  12. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
    Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
    PubMed     Text format     Abstract available



  13. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed     Text format    


  14. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed     Text format    


  15. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Text format     Abstract available


  16. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Text format     Abstract available


    August 2017
  17. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
    Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
    PubMed     Text format     Abstract available


    July 2017
  18. CHEN Z, Wang Y, Kuwana M, Xu X, et al
    HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
    PubMed     Text format     Abstract available


  19. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
    Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
    PubMed     Text format     Abstract available


  20. NAGASHIMA T, Iwamoto M, Minota S
    Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
    J Rheumatol. 2017;44:1099-1100.
    PubMed     Text format    


  21. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
    Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
    PubMed     Text format     Abstract available


    June 2017
  22. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
    Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
    PubMed     Text format     Abstract available


  23. GU K, Gladman DD, Su J, Urowitz MB, et al
    Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
    J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
    PubMed     Text format     Abstract available


  24. KURTZMAN DJB, Weinblatt M, Vleugels RA
    Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    J Rheumatol. 2017;44:850-851.
    PubMed     Text format    


  25. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
    Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
    J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
    PubMed     Text format     Abstract available


    May 2017
  26. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
    Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
    PubMed     Text format     Abstract available


  27. FASANO S, Pierro L, Pantano I, Iudici M, et al
    Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
    PubMed     Text format     Abstract available


  28. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
    Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
    PubMed     Text format     Abstract available


  29. SHI J, Li S, Yang H, Zhang Y, et al
    Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
    PubMed     Text format     Abstract available


  30. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
    Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
    J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
    PubMed     Text format     Abstract available


  31. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
    Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
    PubMed     Text format     Abstract available


  32. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
    Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
    J Rheumatol. 2017;44:711-712.
    PubMed     Text format    


  33. GENEST G, Laskin CA
    Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    J Rheumatol. 2017;44:547-549.
    PubMed     Text format    


    April 2017
  34. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
    PubMed     Text format     Abstract available


  35. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Text format     Abstract available


  36. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Text format     Abstract available


  37. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Text format     Abstract available


  38. YANG N, Bhattacharyya S, Weinblatt M
    Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
    J Rheumatol. 2017;44:541-542.
    PubMed     Text format    


  39. NIHTYANOVA SI, Denton CP
    Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
    J Rheumatol. 2017;44:404-406.
    PubMed     Text format    


    March 2017
  40. ARTIM-ESEN B, Sahin S, Cene E, Sahinkaya Y, et al
    Comparison of Disease Characteristics, Organ Damage, and Survival in Patients with Juvenile-onset and Adult-onset Systemic Lupus Erythematosus in a Combined Cohort from 2 Tertiary Centers in Turkey.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160340. doi: 10.3899/jrheum.160340.
    PubMed     Text format     Abstract available


  41. YUN H, Xie F, Baddley JW, Winthrop K, et al
    Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160685. doi: 10.3899/jrheum.160685.
    PubMed     Text format     Abstract available


  42. KIM SK, Choe JY, Lee SS
    Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    J Rheumatol. 2017 Mar 15. pii: jrheum.160900. doi: 10.3899/jrheum.160900.
    PubMed     Text format     Abstract available


  43. TANNA A, Pusey CD
    The Histopathological Classification of ANCA-associated Glomerulonephritis Comes of Age.
    J Rheumatol. 2017;44:265-267.
    PubMed     Text format    


  44. TUNNICLIFFE DJ, Singh-Grewal D, Craig JC, Howell M, et al
    Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-methods Study.
    J Rheumatol. 2017 Mar 1. pii: jrheum.160720. doi: 10.3899/jrheum.160720.
    PubMed     Text format     Abstract available


    February 2017
  45. TEKTONIDOU MG, Ward MM
    Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015.
    J Rheumatol. 2017 Feb 15. pii: jrheum.160546. doi: 10.3899/jrheum.160546.
    PubMed     Text format     Abstract available


  46. TANSLEY SL, Betteridge ZE, Simou S, Jacques TS, et al
    Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017 Feb 15. pii: jrheum.160871. doi: 10.3899/jrheum.160871.
    PubMed     Text format     Abstract available


  47. NODA K, Yoshida K, Ukichi T, Furuya K, et al
    Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.
    J Rheumatol. 2017 Feb 1. pii: jrheum.160763. doi: 10.3899/jrheum.160763.
    PubMed     Text format     Abstract available


    January 2017
  48. DE BOYSSON H, Liozon E, Lariviere D, Samson M, et al
    Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.
    J Rheumatol. 2017 Jan 15. pii: jrheum.161033. doi: 10.3899/jrheum.161033.
    PubMed     Text format     Abstract available


  49. GOLDER V, Morand EF, Hoi AY
    Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge Gap.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160334. doi: 10.3899/jrheum.160334.
    PubMed     Text format     Abstract available


  50. MOGHADAM-KIA S, Oddis CV, Sato S, Kuwana M, et al
    Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160682. doi: 10.3899/jrheum.160682.
    PubMed     Text format     Abstract available


  51. ORQUEVAUX P, Masseau A, Le Guern V, Gayet V, et al
    In Vitro Fertilization in 37 Women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome: A Series of 97 Procedures.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160462. doi: 10.3899/jrheum.160462.
    PubMed     Text format     Abstract available


  52. ZHU CM, Ma Y, Xie L, Huang JZ, et al
    Spatial Working Memory Impairment in Patients with Non-neuropsychiatric Systemic Lupus Erythematosus: A Blood-oxygen-level Dependent Functional Magnetic Resonance Imaging Study.
    J Rheumatol. 2017 Jan 15. pii: jrheum.160290. doi: 10.3899/jrheum.160290.
    PubMed     Text format     Abstract available


    December 2016
  53. CHEN YX, Xu J, Pan XX, Shen PY, et al
    Histopathological Classification and Renal Outcome in Patients with Antineutrophil Cytoplasmic Antibodies-associated Renal Vasculitis: A Study of 186 Patients and Metaanalysis.
    J Rheumatol. 2016 Dec 15. pii: jrheum.160866.
    PubMed     Text format     Abstract available


  54. RICHTER JG, Sander O, Schneider M
    Causes of Cardiovascular Ischemic Events in Giant Cell Arteritis.
    J Rheumatol. 2016;43:2092-2093.
    PubMed     Text format    


  55. AGGARWAL R, Dhillon N, Fertig N, Koontz D, et al
    A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome.
    J Rheumatol. 2016 Dec 1. pii: jrheum.160618.
    PubMed     Text format     Abstract available


    November 2016
  56. ARMSTRONG SM, Wither JE, Borowoy AM, Landolt-Marticorena C, et al
    Development, Sensibility, and Validity of a Systemic Autoimmune Rheumatic Disease Case Ascertainment Tool.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160327.
    PubMed     Text format     Abstract available


  57. MOHAMMAD AJ, Englund M, Turesson C, Tomasson G, et al
    Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160249.
    PubMed     Text format     Abstract available


  58. HUBER AM, Kim S, Reed AM, Carrasco R, et al
    Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160688.
    PubMed     Text format     Abstract available


  59. LOPEZ DE PADILLA CM, Crowson CS, Hein MS, Pendegraft RS, et al
    Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.
    J Rheumatol. 2016 Nov 1. pii: jrheum.160293.
    PubMed     Text format     Abstract available


    October 2016
  60. FAURSCHOU M, Ahlstrom MG, Lindhardsen J, Obel N, et al
    Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    J Rheumatol. 2016 Oct 15. pii: jrheum.160797.
    PubMed     Text format     Abstract available


  61. LAROCHE M, Seniow M, Roche H, Ruyssen-Witrand A, et al
    Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment.
    J Rheumatol. 2016;43:1945-1946.
    PubMed     Text format    


    September 2016
  62. GAO R, Yu W, Wen Y, Li H, et al
    Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2016 Sep 15. pii: jrheum.151395.
    PubMed     Text format     Abstract available


  63. BACHMEYER C, Galmiche S, Fayand A, Degachi A, et al
    Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence.
    J Rheumatol. 2016;43:1766.
    PubMed     Text format    


  64. SINGH JA, Hossain A, Kotb A, Oliveira A, et al
    Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
    J Rheumatol. 2016 Sep 1. pii: jrheum.160041.
    PubMed     Text format     Abstract available


  65. FORTIN PR, Cloutier N, Bissonnette V, Aghdassi E, et al
    Distinct Subtypes of Microparticle-containing Immune Complexes Are Associated with Disease Activity, Damage, and Carotid Intima-media Thickness in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Sep 1. pii: jrheum.160050.
    PubMed     Text format     Abstract available


  66. PUGNET G, Sailler L, Fournier JP, Bourrel R, et al
    Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.
    J Rheumatol. 2016 Sep 1. pii: jrheum.151500.
    PubMed     Text format     Abstract available


    August 2016
  67. GONZALEZ-GAY MA, Castaneda S, Llorca J
    Giant Cell Arteritis: Visual Loss Is Our Major Concern.
    J Rheumatol. 2016;43:1458-61.
    PubMed     Text format    


  68. NANDIWADA SL, Peterson LK, Mayes MD, Jaskowski TD, et al
    Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
    J Rheumatol. 2016 Aug 1. pii: jrheum.160106.
    PubMed     Text format     Abstract available


  69. HERNANDEZ-MOLINA G, Nunez-Alvarez C, Avila-Casado C, Llorente L, et al
    Usefulness of IgA Anti-alpha-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjogren Syndrome with Negative Anti-SSA/SSB Antibodies.
    J Rheumatol. 2016 Aug 1. pii: jrheum.151315.
    PubMed     Text format     Abstract available


    July 2016
  70. PEREZ-FERRO M, Serrano Del Castillo C, Sanchez-Pernaute O
    Cell Membrane-bound TLR2 and TLR4: Potential Predictors of Active Systemic Lupus Erythematosus and Lupus Nephritis.
    J Rheumatol. 2016;43:1444-5.
    PubMed     Text format    


  71. HERRINTON LJ, Liu L, Goldfien R, Michaels MA, et al
    Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials.
    J Rheumatol. 2016 Jul 1. pii: jrheum.150671.
    PubMed     Text format     Abstract available


    June 2016
  72. MANFREDI A, Sebastiani M, Campomori F, Pipitone N, et al
    Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern.
    J Rheumatol. 2016 Jun 15. pii: jrheum.160122.
    PubMed     Text format     Abstract available


  73. CAO H, Xia Q, Pan M, Zhao X, et al
    Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    J Rheumatol. 2016 Jun 15. pii: jrheum.160024.
    PubMed     Text format     Abstract available


  74. ROBERTS JE, Mandl LA, Su EP, Mayman DJ, et al
    Patients with Systemic Lupus Erythematosus Have Increased Risk of Short-term Adverse Events after Total Hip Arthroplasty.
    J Rheumatol. 2016 Jun 15. pii: jrheum.151373.
    PubMed     Text format     Abstract available


  75. CHEN D, Xie J, Chen H, Yang Y, et al
    Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, Drug Resistance, Outcomes, and Risk Factors.
    J Rheumatol. 2016 Jun 15. pii: jrheum.151523.
    PubMed     Text format     Abstract available


  76. JOO YB, Park SY, Won S, Bae SC, et al
    Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    J Rheumatol. 2016 Jun 1. pii: jrheum.151129.
    PubMed     Text format     Abstract available


  77. SALEH M, Turesson C, Englund M, Merkel PA, et al
    Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2016 Jun 1. pii: jrheum.151033.
    PubMed     Text format     Abstract available


    May 2016
  78. REGENT A, Redeker S, Deroux A, Kieffer P, et al
    Tocilizumab in Giant Cell Arteritis: A Multicentre Retrospective Study of 34 Patients.
    J Rheumatol. 2016 May 15. pii: jrheum.151252.
    PubMed     Text format     Abstract available


  79. CHATRE C, Filippi N, Roubille F, Pers YM, et al
    Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
    J Rheumatol. 2016;43:997-8.
    PubMed     Text format    


  80. SUYAMA Y, Nakayama S, Hagiwara K
    Synovial Chondromatosis of the Suprapatellar Pouch of the Knee in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2016;43:948.
    PubMed     Text format    


  81. KNIGHT AM, Xie M, Mandell DS
    Disparities in Psychiatric Diagnosis and Treatment for Youth with Systemic Lupus Erythematosus: Analysis of a National US Medicaid Sample.
    J Rheumatol. 2016 May 1. pii: jrheum.150967.
    PubMed     Text format     Abstract available


  82. ZHAO L, Xu D, Qiao L, Zhang X, et al
    Bone Marrow Megakaryocytes May Predict Therapeutic Response of Severe Thrombocytopenia in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2016 May 1. pii: jrheum.150829.
    PubMed     Text format     Abstract available


  83. HARA A, Furuichi K, Yamahana J, Yasuda H, et al
    Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    J Rheumatol. 2016 May 1. pii: jrheum.151430.
    PubMed     Text format     Abstract available


  84. HERMANSEN MF, Lindhardsen J, Torp-Pedersen C, Faurschou M, et al
    Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study.
    J Rheumatol. 2016 May 1. pii: jrheum.151221.
    PubMed     Text format     Abstract available


  85. MORA C, Medina-Rosas J, Santos AM, Jaimes DA, et al
    Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 May 1. pii: jrheum.150486.
    PubMed     Text format     Abstract available


  86. LIOZON E, Dalmay F, Lalloue F, Gondran G, et al
    Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 Patients.
    J Rheumatol. 2016 May 1. pii: jrheum.151135.
    PubMed     Text format     Abstract available


    April 2016
  87. LEGGE A, Doucette S, Hanly JG
    Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Apr 15. pii: jrheum.150985.
    PubMed     Text format     Abstract available


  88. ROBSON JC, Kiran A, Maskell J, Hutchings A, et al
    Which Patients with Giant Cell Arteritis Will Develop Cardiovascular or Cerebrovascular Disease? A Clinical Practice Research Datalink Study.
    J Rheumatol. 2016 Apr 15. pii: jrheum.151024.
    PubMed     Text format     Abstract available


  89. ZHOU D, Wang Y, Chen LU, Zhang W, et al
    Soluble CD163: A Novel Biomarker with Diagnostic and Therapeutic Implications in Autoimmune Diseases.
    J Rheumatol. 2016;43:830-1.
    PubMed     Text format    


  90. KERMANI TA, Cuthbertson D, Carette S, Hoffman GS, et al
    The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.
    J Rheumatol. 2016 Apr 1. pii: jrheum.151063.
    PubMed     Text format     Abstract available


  91. AKSOY A, Solmaz D, Can G, Cetin P, et al
    Increased Frequency of Hand Osteoarthritis in Patients with Primary Sjogren Syndrome Compared with Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Apr 1. pii: jrheum.150841.
    PubMed     Text format     Abstract available


  92. CHALAN P, Bijzet J, Kroesen BJ, Boots AM, et al
    Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis are Associated with Autoantibody Status.
    J Rheumatol. 2016 Apr 1. pii: jrheum.150644.
    PubMed     Text format     Abstract available


  93. KNIGHT AM, Vickery ME, Muscal E, Davis AM, et al
    Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada.
    J Rheumatol. 2016 Apr 1. pii: jrheum.151228.
    PubMed     Text format     Abstract available


  94. CONSOLARO A, Ravelli A
    Unraveling the Phenotypic Variability of Juvenile Idiopathic Arthritis across Races or Geographic Areas--Key to Understanding Etiology and Genetic Factors?
    J Rheumatol. 2016;43:683-5.
    PubMed     Text format    


  95. MEDAVARAM S, Xue F, Lahita R
    IgG4 Syndrome Presenting as Leptomeningitis in a Young Woman.
    J Rheumatol. 2016;43:828-9.
    PubMed     Text format    


  96. CONSTANTIN T, Foeldvari I, Vojinovic J, Horneff G, et al
    Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.
    J Rheumatol. 2016;43:816-24.
    PubMed     Text format     Abstract available


  97. EVENSEN K, Aulie HA, Ronning OM, Flato B, et al
    Carotid Atherosclerosis in Adult Patients with Persistently Active Juvenile Idiopathic Arthritis Compared with Healthy Controls.
    J Rheumatol. 2016;43:810-5.
    PubMed     Text format     Abstract available


  98. FITZPATRICK L, Broadaway KA, Ponder L, Angeles-Han ST, et al
    Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
    J Rheumatol. 2016;43:799-803.
    PubMed     Text format     Abstract available


  99. EHRMANN FELDMAN D, Vinet E, Bernatsky S, Duffy C, et al
    Birth Outcomes in Women with a History of Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016;43:804-9.
    PubMed     Text format     Abstract available


    March 2016
  100. KIM K, Bang SY, Joo YB, Kim T, et al
    Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.
    J Rheumatol. 2016 Mar 15. pii: jrheum.150665.
    PubMed     Text format     Abstract available



  101. Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
    J Rheumatol. 2016;43:681.
    PubMed     Text format    


    February 2016
  102. UROWITZ MB, Ibanez D, Su J, Gladman DD, et al
    Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Feb 15. pii: jrheum.150983.
    PubMed     Text format     Abstract available


  103. GLUSHKO T, Marcus VA, Colmegna I
    Cytomegalovirus-induced Colon Perforation in Systemic Lupus Erythematosus.
    J Rheumatol. 2016;43:459-60.
    PubMed     Text format    


  104. PEK EA, Joseph PL, Al Habeeb AS, Albert LJ, et al
    A Fatal Case of Calciphylaxis in a Patient with Systemic Lupus Erythematosus and Normal Renal Function.
    J Rheumatol. 2016;43:456-8.
    PubMed     Text format    


  105. DURCAN L, Winegar DA, Connelly MA, Otvos JD, et al
    Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    J Rheumatol. 2016 Feb 1. pii: jrheum.150437.
    PubMed     Text format     Abstract available


  106. KAPUSTA MA
    A Portrait of Juvenile Arthritis with Multiple Joint Abnormalities.
    J Rheumatol. 2016;43:450-1.
    PubMed     Text format    


    January 2016
  107. HINOJOSA-AZAOLA A, Romero-Diaz J, Vargas-Ruiz AG, Nunez-Alvarez CA, et al
    Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150506.
    PubMed     Text format     Abstract available


  108. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150779.
    PubMed     Text format     Abstract available


  109. ALSOLAIMANI RS, Bhavsar SV, Khalidi NA, Pagnoux C, et al
    Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150143.
    PubMed     Text format     Abstract available


  110. BROYDE A, Arad U, Madar-Balakirski N, Paran D, et al
    Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150397.
    PubMed     Text format     Abstract available


  111. HUANG X, Magder LS, Petri M
    Predictors of Incident Seizure in Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150135.
    PubMed     Text format     Abstract available


  112. ZHANG L, Xu D, Yang H, Tian X, et al
    Clinical Features, Morbidity, and Risk Factors of Intestinal Pseudo-obstruction in Systemic Lupus Erythematosus: A Retrospective Case-control Study.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150074.
    PubMed     Text format     Abstract available


  113. HO RC, Ong H, Thiaghu C, Lu Y, et al
    Genetic Variants That Are Associated with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2016 Jan 15. pii: jrheum.150884.
    PubMed     Text format     Abstract available


  114. ROTHSCHILD B
    Serine Proteases in Systemic Lupus Erythematosus: The Other Half of the Story.
    J Rheumatol. 2016;43:253.
    PubMed     Text format    


  115. BONROY C, Smith V, Deschepper E, DE Keyser F, et al
    Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
    J Rheumatol. 2016;43:247-9.
    PubMed     Text format    


  116. LI YC, Yeh FC, Chen HC
    Extensive Lipoatrophy on a Buttock Revealing Systemic Lupus Erythematosus Panniculitis.
    J Rheumatol. 2016;43:180-1.
    PubMed     Text format    


  117. SASAKI H, Yamazaki H, Kohsaka H
    A Case of ANCA-associated Large Vessel Vasculitis with Multiple Saccular Aneurysms.
    J Rheumatol. 2016;43:179.
    PubMed     Text format    


  118. MCGEOCH L, Twilt M, Famorca L, Bakowsky V, et al
    CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides.
    J Rheumatol. 2016;43:97-120.
    PubMed     Text format     Abstract available


  119. NUSMAN CM, Ording Muller LS, Hemke R, Doria AS, et al
    Current Status of Efforts on Standardizing Magnetic Resonance Imaging of Juvenile Idiopathic Arthritis: Report from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:239-44.
    PubMed     Text format     Abstract available


    December 2015
  120. PEREZ-PENATE GM, Rua-Figueroa I, Julia-Serda G, Leon-Marrero F, et al
    Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.
    J Rheumatol. 2015 Dec 15. pii: jrheum.150451.
    PubMed     Text format     Abstract available


  121. XU D, Huang CC, Kachaochana A, Morgan GA, et al
    MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis.
    J Rheumatol. 2015 Dec 1. pii: jrheum.141474.
    PubMed     Text format     Abstract available


  122. KAY SD, Poulsen MK, Diederichsen AC, Voss A, et al
    Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Dec 1. pii: jrheum.150488.
    PubMed     Text format     Abstract available


    November 2015
  123. YANG Y, Kumar S, Lim LS, Silverman ED, et al
    Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150464.
    PubMed     Text format     Abstract available


  124. SABIO JM, Martinez-Bordonado J, Sanchez-Berna I, Vargas-Hitos JA, et al
    Nighttime Blood Pressure Patterns and Subclinical Atherosclerosis in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150531.
    PubMed     Text format     Abstract available


  125. TSELIOS K, Sheane BJ, Gladman DD, Urowitz MB, et al
    Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150460.
    PubMed     Text format     Abstract available


  126. STEIMAN AJ, Gladman DD, Ibanez D, Noamani B, et al
    Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150040.
    PubMed     Text format     Abstract available


  127. SILVA MF, Ferriani MP, Terreri MT, Pereira RM, et al
    A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2015 Nov 15. pii: jrheum.150142.
    PubMed     Text format     Abstract available


  128. KILIC E, Kilic G, Ozgocmen S
    Diurnal Variation in Distal Femoral Cartilage Thickness.
    J Rheumatol. 2015;42:2215.
    PubMed     Text format    


    September 2015
  129. STOLL ML, Vaid YN, Guleria S, Beukelman T, et al
    Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Sep 1. pii: jrheum.150308.
    PubMed     Text format     Abstract available


    June 2015
  130. LOCHBUHLER N, Saurenmann RK, Muller L, Kellenberger CJ, et al
    Magnetic Resonance Imaging Assessment of Temporomandibular Joint Involvement and Mandibular Growth Following Corticosteroid Injection in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Jun 1. pii: jrheum.141502.
    PubMed     Text format     Abstract available


    May 2015
  131. SALTMAN AP, Tseng E, Bunce PE, Albert L, et al
    Double trouble: a case of concurrent opportunistic infections.
    J Rheumatol. 2015;42:903-4.
    PubMed     Text format    


  132. SHUKLA A, Gaur P, Aggarwal A
    Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study.
    J Rheumatol. 2015;42:891-6.
    PubMed     Text format     Abstract available


    April 2015
  133. SANTIAGO MB, Machicado V, Ribeiro DS
    "Mutilans-type" Jaccoud Arthropathy.
    J Rheumatol. 2015;42:725-6.
    PubMed     Text format    


  134. YOKOTA S, Itoh Y, Morio T, Sumitomo N, et al
    Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
    J Rheumatol. 2015;42:712-22.
    PubMed     Text format     Abstract available


  135. TAPPEINER C, Miserocchi E, Bodaghi B, Kotaniemi K, et al
    Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.
    J Rheumatol. 2015;42:706-11.
    PubMed     Text format     Abstract available


  136. KNIGHT A, Hjorton K, Sundstrom C, Hoglund M, et al
    Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome.
    J Rheumatol. 2015;42:690-4.
    PubMed     Text format     Abstract available


    March 2015
  137. MAGNI-MANZONI S
    Ultrasound measurement of cartilage thickness in childhood arthritis - target the tissue, tailor the technique.
    J Rheumatol. 2015;42:360-2.
    PubMed     Text format    


  138. BURCHETTE RJ
    Is there hope for juvenile idiopathic arthritis patient-reported outcomes in support of clinical decisions?
    J Rheumatol. 2015;42:358-9.
    PubMed     Text format    


  139. SCHER JU
    Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.
    J Rheumatol. 2015;42:355-7.
    PubMed     Text format    


  140. PRADSGAARD DO, Fiirgaard B, Spannow AH, Heuck C, et al
    Cartilage thickness of the knee joint in juvenile idiopathic arthritis: comparative assessment by ultrasonography and magnetic resonance imaging.
    J Rheumatol. 2015;42:534-40.
    PubMed     Text format     Abstract available


  141. DIJKSTRA ME, Anink J, van Pelt PA, Hazes JM, et al
    Patient-reported joint count in juvenile idiopathic arthritis: the reliability of a manikin format.
    J Rheumatol. 2015;42:527-33.
    PubMed     Text format     Abstract available


  142. ARVONEN M, Virta LJ, Pokka T, Kroger L, et al
    Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?
    J Rheumatol. 2015;42:521-6.
    PubMed     Text format     Abstract available


    July 2014
  143. ZHU TY, Griffith JF, Au SK, Tang XL, et al
    Bone Mineral Density Change in Systemic Lupus Erythematosus: A 5-year Followup Study.
    J Rheumatol. 2014 Jul 1. pii: jrheum.131190.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: